Association between the insulin-like growth factor 1 gene rs2195239 and rs2162679 polymorphisms and cancer risk: a meta-analysis
Association between the insulin-like growth factor 1 gene rs2195239 and rs2162679 polymorphisms and cancer risk: a meta-analysis
复制标题
胰岛素样生长因子 1 基因 rs2195239 和 rs2162679 多态性与癌症风险之间的关联:荟萃分析
DOI:
10.1186/s12881-019-0749-3
复制
发表时间:
2019-01-17
影响因子:
--
通讯作者:
Wu,Li-Fang
中科院分区:
文献类型:
--
作者:
Xu,Gui-Ping;Chen,Wei-Xian;Wu,Li-Fang
BackgroundMany epidemiological studies have suggested that insulin-like growth factor1 (IGF1) gene single-nucleotide polymorphisms (SNPs) may be associated with cancer risk. Among several commonly studied polymorphisms inIGF1gene, rs2195239 and rs2162679 attracted many attentions. So we perform a meta-analysis to determine potential associations betweenIGF1rs2195239 and rs2162679 polymorphisms and cancer risk.MethodsWe retrieved relevant articles from the PubMed, Embase, and Web of Science databases up to April 30, 2018. Ultimately, thirteen studies were included in the present meta-analysis, which involved 12,515 cases and 19,651 controls. The odd ratios (ORs) and their 95% confidence intervals (CIs) were pooled to estimate the strength of the associations.Resultsrs2195239 reduces the overall cancer risk in homozygote model, as well as reducing cancer risk in Asian populations in allele, homozygote, and recessive models. No significant relationship was found between rs2195239 and breast or pancreatic cancer risk. rs2162679 reduces the overall cancer risk in allele, homozygote, dominant, and recessive models, as well as reducing cancer risk in Asian populations in allele, homozygote, and recessive models.ConclusionsIGF1rs2195239 and rs2162679 were associated with overall cancer risk based on present studies.